Effect of Parcetamol in Headach
Launched by ASSIUT UNIVERSITY · Mar 1, 2025
Trial Information
Current as of July 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how effective and safe paracetamol (also known as acetaminophen) is for treating frequent tension-type headaches (TTH) in adults. Tension-type headaches are a common type of headache that can happen two to 14 times a month. The goal of the trial is to see if paracetamol can help relieve these headaches when they occur.
To participate in the trial, you need to be between 18 and 65 years old and must not have any serious brain conditions or migraines. If you join the study, you will take paracetamol when you have a headache, and researchers will monitor how well it works for you. It’s important to know that the trial is not yet recruiting participants, but if you fit the criteria, you may be eligible to join once it starts.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • both sex
- • 18 years old to 65 years
- • free ct brain
- Exclusion Criteria:
- • migrane
- • any brain pathology
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported